Retraction Notice: Protein Identification in Sub Proteome Fractions of Breast Cancer Cells by OFFGEL-IEF and iTRAQ Labeling
Journal:
Current Proteomics
Volume:
6
Page:
43-50
Author(s):
K.H. Chandramouli*, Pushpa Agrawal and K.N. Thimmaiah
Nitric Oxide: Cancer Target or Anticancer Agent?
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
214-236
Author(s):
Simone Mocellin
Chromatin Structure and Epigenetics of Tumour Cells: A Review
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
9
Page:
51-61
Author(s):
Eva Bartova, Jana Krejci, Roman Hajek, Andrea Harnicarova and Stanislav Kozubek
Molecular Basis of the Anti-Inflammatory Effects of Terpenoids
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
8
Page:
28-39
Author(s):
B. de las Heras and Sonsoles Hortelano
Glucans as Biological Response Modifiers
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
67-75
Author(s):
M. Novak and V. Vetvicka
Research Toward Potassium Channels on Tumor Progression
Journal:
Current Topics in Medicinal Chemistry
Volume:
9
Page:
322-329
Author(s):
Zheng Shen, Qian Yang and Qidong You
Drug Discoveries Towards Kv1.5 Potassium Channel
Journal:
Current Topics in Medicinal Chemistry
Volume:
9
Page:
339-347
Author(s):
Qian Yang, Xiaojian Wang, Lupei Du, Minyong Li and Qidong You
Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
Journal:
Current Drug Discovery Technologies
Volume:
6
Page:
72-81
Author(s):
Kurt Van der Speeten, Oswald Anthony Stuart and Paul H. Sugarbaker
Targeting the Immune System in Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
166-184
Author(s):
Devyani Chaudhuri, Robert Suriano, Abraham Mittelman and Raj K. Tiwari
Targeting Histone Deacetylases in Neuroblastoma
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
436-447
Author(s):
O. Witt, H. E. Deubzer, M. Lodrini, T. Milde and I. Oehme